Elevated cholesteryl ester transfer protein activity early in pregnancy predicts prediabetes 5 years later.
Cholesteryl ester transfer protein (CETP) regulates high density lipoproteins (HDL)-cholesterol levels and interaction between glucose and HDL metabolism is central in the development of diabetes. We hypothesized that CETP levels would be regulated in diabetic pregnancies. We tested the hypothesis by evaluating CETP activity measured multiple times during pregnancy and at 5 years follow-up in a prospective cohort (STORK) and investigated its association with gestational diabetes mellitus (GDM) during pregnancy or development of prediabetes 5 years after pregnancy. We also evaluated the strongest correlated of CETP activity among measures of adipocity and glucose metabolism, lipoproteins, adipokines and monocyte/macrophage activation markers. Population-based longitudinal cohort study from 2001 to 2013. Oslo University Hospital. 300 women during pregnancy and at 5 years postpartum. CETP activity measured at 14-16, 22-24, 30-32, 36-38 weeks gestation, and at 5 years follow-up. We found higher CETP activity in pregnancy in women developing prediabetes but no association with GDM. CETP activity decreased throughout pregnancy and remained low at follow-up. High CETP activity was associated with sCD14 levels, in particular in women who developed prediabetes. These data show that enhanced CETP activity during pregnancy is associated with systemic indices of monocyte/macrophage activation, in particular in women who develop prediabetes later in life. CETP activity during pregnancy identified women at risk for later diabetes development.